Replies to post #728881 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

You do know that poly-iclc must be combined with DCVax-L, don't you? Now enlighten the longs with your critical thinking skills what are the implications of the following news. I guess you cannot elaborate. Otherwise you wouldn't do this sp prediction game, which strikes me you have nothing to contribute.

https://www.vcpost.com/articles/126732/20240521/partner-with-biotechnologys-oncovir-to-build-a-healthier-future-for-all.htm

Working Together to Solve Oncology Challenges

Oncovir's other partnerships, while confidential, are also essential to the team's commercialization and continued scientific research. "We have them in different regulatory areas in the world, some of them are in Europe, some of them are in the United States."

One of Oncovir's priorities is partnering with companies that are combining their own products with Hiltonol with the aim of addressing critical oncology challenges for patients. Currently, many of their partners' efforts are focused on conducting trials to demonstrate its efficacy and safety.

While their partners are supporting Oncovir financially, the team is also looking for additional partners who are inspired by their work and driven to help them propel the development cycle and get this life-saving product into as many hands as possible.

It's an exciting and profitable time to consider partnering with innovative biotechnology companies. As the industry continues to accelerate with its breakthrough therapies and novel treatments, the potential to create a healthier future for all is at our fingertips. With Oncovir's potential to address unmet medical needs, improve patient outcomes, and potentially revolutionize cancer therapy on a global scale, there is no better or more profitable time to become their partner.